Mopson Pharmaceuticals Limited

MOPSON Pharmaceutical Limited develops, produces, and markets drugs licensed for use as medications. MOPSON pharmaceutical limited are makers of both ethical and generic medications The Company’s products are all registered with the National Agency for Food and Drugs Administration Control (NAFDAC) in compliance with the statutory regulation.

MOPSON Pharmaceutical Limited has been in the business of manufacturing and supply of medicines since 1980. The company has been the preferred supplier of most of the pharmaceutical requirements of government institutions like the Government Hospitals, University Teaching Hospitals, industrial clinics, private hospitals and clinics in Nigeria.

Today, the company is reputed for the quality of its pharmaceutical products with over 50 products developed by in-house research and development division of the firm.

OUR HISTORY AND SUCCESS STORY

Mopson Pharmaceutical Company has been the preferred choice of supplier for most of the government hospitals, institutions in Nigeria.

Michael Oyebanjo Paul

Dr. Michael Oyebanjo Paul, Chairman of Mopson Pharmaceutical Limited was born on the 4th of April 1948, at Odolewu village (near Ijebu Ode) in Ogun State. He had his secondary School Education at St. John’s College, Ile-Ife from 1962 – 1966. He worked briefly as an Immigration Officer before going to the Federal School of Science Lagos in 1969. He attended the then University of Ife, Ile-Ife, now, Obafemi   Awolowo University where he graduated as a Pharmacist in 1973. He started Mopson Pharmaceutical as a Compounding Chemist in 1980 at 24, Itire Road, Surulere and the company now has its ultramodern head office at No 47 Isolo Way, Ajao Estate, and Lagos.

He is the recipient of several commendations and awards for his industrial and charitable prowess. In 1998, he received the “ECOWAS Gold Award” in recognition of his distinguished entrepreneurial endeavor. Same year, he was recognized as “Man of the Year” by the Guardian Newspaper. He also received from the Rotary Club an award “Industrialist of the Year” in 1998. In 1999, he received the “Prestigious Leadership Award of Excellence” from the Science Teachers Association of Nigeria and “Eminent Persons Award” from the Nigerian Associations of Industrial Pharmacists. In 2002, he became a fellow of the prestigious West African Postgraduate College of Pharmacy. He is also a fellow of the Pharmaceutical Society of Nigeria. On the 4th July 2013, he became a recipient of an honorary Doctor of Business Administration degree (DBA) from the reputable Commonwealth University. Dr. Michael Oyebanjo Paul, Chairman/Managing Director, Mopson Pharmaceutical Ltd, is a devout Christian and a philanthropist. He is married and blessed with children.

Mopson Pharmaceutical Limited

Mopson Pharmaceutical Limited is a NIS ISO 9001:2015 certified company. It is a limited liability company incorporated under the Nigerian Companies’ Act. It started operations in 1977.

Award Research and Development

All Mopson products are award-winning and were developed by the company’s research and Development Laboratory. For example, Neofylin cough syrup was adjudged as Africa’s best cough mixture of the year 2006 and Asmalyn syrup won the best Asthma management award in 2012. Thus, his products have been tagged “Products of excellence” nationally and internationally. In 1992, the company started a research project to develop stable and potent Vitamin C syrup. Two institutions, University of Lagos and University of Ibadan were involved under the guidance of Professor Olaniyi of the University of Ibadan and Professor Fola Tayo of the University of Lagos. The project was successful and this led to the birth of Ascorbion C 300 which today is the most stable, most potent and most affordable Vitamin C syrup in the market with less than 5% loss after ten years.